The FDA is evaluating Actos for a possible link to bladder cancer. Preliminary results from a long-term observational study found an increased risk of bladder cancer in patients with the longest exposure to Actos and the highest cumulative dose of the drug.

This material is for informational purposes only and does not constitute legal advice. No representation is made that the quality of legal services to be performed is greater than the quality of legal services performed by other lawyers.

About Legal Briefs
Legal Briefs addresses various topics of public interest including recalls, public safety, breaking news and important verdicts and settlements. These episodes of "Legal Briefs" brought to you by Lauren Thompson, help keep the public informed, raise awareness and promote safety and justice.

Recorded: June 17, 2011

Courtesy of: BEASLEY ALLEN

Keywords: Pharmaceutical, General Pharmaceutical